PNS Daily Newscast - November 13, 2019 

Public impeachment hearings in Washington; dreamers protest in Texas; roadless wilderness areas possibly at risk around the country; and an ozone indicating garden, at the North Carolina Governor's Mansion.

2020Talks - November 13, 2019 

Supreme Court hears DACA arguments, and likely will side with the Trump administration, but doesn't take up a gun manufacturer's appeal. Former SC Gov. Mark Sanford drops out of presidential race; and former President Jimmy Carter recovers from brain surgery.

Daily Newscasts

Report: Soaring Prescription Costs Overwhelming Washingtonians

The annual cost of the name-brand cancer-treating drug REVLIMID rose roughly $100,000 between 2012 and 2017. (Burlingham/Adobe Stock)
The annual cost of the name-brand cancer-treating drug REVLIMID rose roughly $100,000 between 2012 and 2017. (Burlingham/Adobe Stock)
September 10, 2019

SEATTLE — New research shows the rising cost of prescription drugs is harming the Washingtonians who need them most.

The average annual cost of prescription drugs grew 57% between 2012 and 2017, according to data compiled by AARP Washington. Over that same period, annual incomes in the state increased about 10%.

In 2016, close to one-third of Washingtonians stopped taking their medications as prescribed due to cost.

Cathy MacCaul, advocacy director for AARP Washington, said people have been making tough choices because of a lack of affordability.

"We have heard stories from individuals here in Washington that have basically said, 'I'm having to make decisions about paying for my prescription drugs or buying food,’” MacCaul said. “And in this day and age, and in the wealthiest nation in the world, people should not have to make those kinds of decisions."

The AARP research also highlighted price increases for name-brand drugs that treat cancer, diabetes and heart disease. For instance, the average cost over a year for the cancer-treating drug REVLIMID rose $100,000 between 2012 and 2017. More than 700,000 Washingtonians were living with cancer in 2017.

AARP has launched a nationwide campaign known as Stop Rx Greed to curb the rising costs of prescription drugs. MacCaul said Congress needs to address this issue now that lawmakers are back in session.

"We think that that really is an indicator that the system is broken and government is broken, and drug companies are continuing to make billions in profits off of seniors and hard-working Americans,” she said.

MacCaul said there's also a need to tackle this at the state level. Washington is among 29 states to pass laws this year aimed at reining in drug prices. Washington’s law will help the state track how prescription costs affect health-care costs overall.

MacCaul said she hopes the Legislature takes it a step further during the 2020 session and makes that information transparent to consumers.

Disclosure: AARP Washington contributes to our fund for reporting on Consumer Issues, Health Issues, Senior Issues. If you would like to help support news in the public interest, click here.
Eric Tegethoff, Public News Service - WA